Where is AI-transcribed medical data stored?

Where is AI-transcribed medical data stored? Discover 2026 EU cloud compliance, GDPR safeguards, audio retention policies, and why location matters for clinicians.

11 Jun 2026 13 min read

Where is AI-transcribed medical data stored?

Clinicians trust voice to capture encounter details. Yet most cannot name the country where their AI scribe's servers live.

AI scribes capture audio of clinical encounters and generate transcripts and structured clinical notes, yet vendor practices differ substantially in how long each data type is retained and whether it is used for AI training. Choosing a medical transcription vendor without understanding where patient data travels, how long it remains accessible, and which legal framework governs it exposes your clinic to compliance risk and patient trust failure.

This article walks through the layers of AI medical data storage in 2026: physical server location, cloud provider compliance, retention policies that distinguish audio from text, and the regulatory guardrails that differ across the Atlantic. You will leave knowing the right questions to ask before signing a contract.

Why data location matters for clinical AI tools

Geography is not an IT detail—it is a legal boundary.

The GDPR recognises data concerning health as a special category of data and provides a definition for health data for data protection purposes. Health data processed within the European Economic Area must comply with GDPR's Chapter V transfer restrictions, which limit movement to countries the European Commission has deemed adequate.

Access to data in the EHDS will be performed only on an EU infrastructure and according to robust technical, organizational, and security requirements determined by the EU policymakers.

In practice, this means EU-based clinicians must verify that any AI medical scribe stores data on EU-based servers or within an adequacy framework. The GDPR applies to controllers and processors regardless of where personal data is processed, as long as the data subject resides in the EU. A vendor running EU patient data through US-based cloud infrastructure without a valid transfer mechanism—standard contractual clauses, adequacy decision, or binding corporate rules—violates Article 44.

For US clinicians, the obligation shifts to HIPAA's Security Rule: encrypted storage, audit logs, and a signed Business Associate Agreement. But because HIPAA does not mandate data residency, many US vendors store clinical transcripts in geographically distributed cloud regions, sometimes outside the United States, which raises unexpected questions when a European patient travels or when an academic collaboration crosses borders.

Cloud infrastructure and AI medical transcription in 2026

AI scribes rely on cloud infrastructure to run speech recognition, large language model processing, and storage at scale.

Ambient scribing tools may generate multiple data artifacts beyond the finalized clinical note, including raw audio recordings and conversation transcripts, draft outputs, prompts entered by users and provenance logs, yet governance of these data streams is often unspecified. Each artifact may land in a different storage tier with its own retention policy and encryption standard.

Raw audio may reside in hot object storage for real-time transcription, intermediate drafts in database clusters, and final notes in long-term archival buckets.

The most important issue is to ensure security and privacy—in other words, to ensure the confidentiality, integrity, and availability of the data. Encryption at rest and in transit are baseline requirements, but the physical location of encryption keys can determine compliance. If keys reside in the same region as the data, a lawful government request in that jurisdiction can compel decryption. Key management services hosted outside the data region add a layer of jurisdictional independence.

European health systems increasingly require cloud providers to demonstrate GDPR-specific certifications: ISO/IEC 27001, ISO/IEC 27018 for personal data in public cloud, and sector-specific codes of conduct for cloud infrastructure service providers under GDPR Article 40. The GDPR full text sets out the legal framework; implementation varies by Member State.

Audio retention policies: what happens after transcription?

The technology leverages a smartphone microphone to transcribe encounters as they occur but does not retain audio recordings. That describes one category of ambient AI scribes. Other vendors follow different policies.

Health systems need to define what to retain, the duration of retention, and access controls, with clear distinction between transient processing data and records that are legally binding. For example, raw audio and intermediate transcripts may be deleted after clinician verification, while finalized notes and minimal provenance metadata are retained.

Audio deletion timelines vary widely. Some vendors delete raw recordings within minutes of transcription completion. Others retain audio for quality assurance, model retraining, or dispute resolution, with retention windows ranging from days to indefinitely. Patients and providers may have concerns because the process generates a full transcript of a clinical encounter, which is not part of the medical record and therefore remains legally discoverable.

An audio file stored for model improvement is discoverable under subpoena, even if the note itself was edited by the clinician.

Best practice in 2026: audio should be purged as soon as the structured note is verified, unless a specific legal or clinical workflow justifies longer retention. MedicMic, for example, physically deletes audio one hour after processing, retaining only the transcript and structured output accessible to the originating clinician.

For clinicians evaluating vendors, ask: (a) What is your audio retention policy? (b) Where is the audio stored while it exists? (c) Can you prove deletion, and is deletion logged in an audit trail? Vendors who cannot answer all three should be deprioritised.

EU data residency and the European Health Data Space

The European Union launched the European Health Data Space (EHDS) in March 2025 to streamline access to and sharing and reuse of health data across all 27 Member States, giving patients greater control over electronic health records and permitting secondary use of data for research, policy, and innovation under strong safeguards.

The EHDS regulation applies from 26 March 2026, though different aspects shall apply in a staggered manner, after entering into force on March 26, 2025. By mid-2026, national contact points for secondary use of health data will begin defining how cloud-based clinical tools align with the new interoperability and security requirements.

The EHDS will allow more effective, accessible and resilient healthcare and better quality of life, while giving individuals control over their health data and unleashing the potential of the data economy. For AI scribes, this means vendors serving EU clinics will be expected to demonstrate that transcription infrastructure resides within the European Economic Area or a jurisdiction with an active adequacy decision.

Clinicians should confirm with vendors: Are your inference servers and storage buckets hosted exclusively in EU regions? If not, which standard contractual clauses or binding corporate rules govern the transfer? The EHDS formalises what GDPR implied—health data stays within trusted jurisdictions unless explicit safeguards apply.

US-based servers and transatlantic data flows

In July 2023, the United States and the European Union introduced the Data Privacy Framework (DPF), the third generation of cross-border data transfer agreements under the GDPR, which may be used in cross-border healthcare and research relationships. The DPF replaced the invalidated Privacy Shield and allows US companies that self-certify to receive personal data from the EU under an adequacy mechanism.

Less than two months after its adoption, the DPF was challenged before the Court of Justice of the European Union, and expectations abound that it will not provide a long-term solution for EU-US data transfers. For AI medical scribes, reliance on the DPF introduces legal uncertainty. If the framework is invalidated—following the pattern of Safe Harbour and Privacy Shield—vendors will scramble to implement standard contractual clauses retroactively, and clinics may face data protection authority audits.

US vendors serving EU clinics should therefore layer safeguards: DPF certification plus standard contractual clauses, encryption with EU-hosted key management, and an option to store EU patient data exclusively in EU cloud regions. Relying on DPF alone is operationally convenient in early 2026 but strategically fragile.

For US clinics, transatlantic risk is lower but not absent. Academic health systems collaborating with European partners on multisite trials must ensure that shared transcripts or clinical notes derived from AI scribes comply with both HIPAA and GDPR. A HIPAA-compliant BAA does not satisfy GDPR's Chapter V transfer requirements, and vice versa.

How to verify where your AI scribe stores data

Vendor marketing pages rarely disclose server locations. Contracts sometimes do, buried in schedules or appendices.

Start with these three requests:

1. Data Processing Addendum or GDPR Annex. This document must list the location of data centres, subprocessors, and cloud providers. If the vendor refuses to share it before contract signature, walk away.

2. Subprocessor list. AI scribes often rely on third-party cloud providers (AWS, Google Cloud, Microsoft Azure) and speech recognition APIs. Each subprocessor introduces another jurisdiction and another set of compliance obligations. Confirm that all subprocessors operate within the same legal framework you require.

3. Audit logs or deletion certificates. If the vendor promises audio deletion within a defined window, request proof. Some vendors generate automated deletion logs with hash verification; others have no mechanism beyond trust.

For EU clinicians, confirm the vendor's cloud region selection. AWS eu-west-1 (Ireland), eu-central-1 (Frankfurt), and eu-south-1 (Milan) are EU-based. US-east-1 (Virginia) is not, regardless of encryption or contractual promises. If your patient data touches a US region, GDPR Chapter V applies.

MedicMic operates as a web application installable as a progressive web app, with inference and storage hosted exclusively in EU cloud regions. Audio is deleted one hour after processing, transcripts remain accessible only to the originating clinician, and no data is shared for model training or third-party analytics.

Retention obligations under medical record laws

AI-generated clinical notes, once incorporated into the electronic health record, fall under the same retention obligations as handwritten or dictated notes.

In the European Union, retention periods for medical records vary by Member State but typically range from five to thirty years after the last patient contact, depending on the record type and the patient's age. The EU Medical Devices Regulation 2017/745 governs retention for device-associated documentation; EHR retention is set by national law.

In the United States, HIPAA does not mandate a specific retention period; state law controls. Most states require retention for a minimum of six to seven years, with longer periods for paediatric records. If an AI scribe's storage policy auto-deletes notes after three years, the clinic violates retention law unless it has migrated the note to a compliant long-term archive.

The critical distinction: retention requirements apply to the final clinical note, not to intermediate drafts or raw audio. Raw audio and intermediate transcripts may be deleted after clinician verification, while finalized notes and minimal provenance metadata are retained to support auditability and dispute resolution. Clinicians should ensure vendor deletion policies align with this distinction—early deletion of audio is good privacy hygiene; early deletion of verified notes is a compliance failure.

Privacy-enhancing alternatives: on-device and federated models

Privacy preservation in healthcare AI has become a critical research focus, with strategies including deidentification, differential privacy, synthetic data generation, and locally deployed models for better privacy.

On-device AI transcription runs speech recognition and note generation entirely on the clinician's local hardware—laptop, tablet, or high-specification smartphone—without sending audio or text to a cloud server. This eliminates data location risk entirely. Performance remains constrained by local GPU capability, and model updates require manual distribution, but for small practices in jurisdictions with strict data localisation laws, the trade-off is acceptable.

Technical measures that do not involve actual data transfers include data visitation, federated analyses, and other privacy-enhancing innovations, but currently are still riddled with practical and legal limitations for their employment. Federated learning allows an AI model to train across multiple sites without aggregating patient data centrally. Each clinic holds its own transcripts; the model learns from distributed patterns. The approach shows promise for multisite research but remains immature for routine clinical documentation workflows.

For most clinics, hybrid architecture offers the best balance: audio processed on-device or in a regional edge node, with only the de-identified structured output uploaded to a central EHR. This minimises exposure of raw conversation while preserving the convenience of cloud-based template management and reporting.

Frequently asked questions

The vendor's legal registration does not determine data location. A company incorporated in Ireland may run all infrastructure on US-based AWS regions. Request the Data Processing Addendum and confirm the specific cloud regions listed. EU-based regions include Ireland, Frankfurt, Paris, Milan, Stockholm, and Spain.

Not legally. Under GDPR Article 28(3)(a), any change to subprocessors or processing locations must be notified in advance, and you retain the right to object. US vendors under HIPAA must also notify material changes to Business Associate Agreements. Check your contract for the notification mechanism—some vendors email updates, others post changes to a public changelog.

Yes. Deletion of the audio file does not shield the transcript, draft notes, or provenance metadata from legal discovery. Patients and providers may have concerns because the process generates a full transcript of a clinical encounter, which is not part of the medical record and therefore remains legally discoverable. If your jurisdiction requires you to avoid documenting specific sensitive topics, review AI-generated transcripts manually before incorporation into the EHR.

Your contract should include data return and deletion obligations upon termination. Request an export in structured format (JSON, FHIR) and written confirmation of deletion within a defined window—typically thirty days. If the vendor is acquired, data processing obligations transfer to the acquirer, but you retain the right to terminate if the new entity's infrastructure or policies breach your original compliance requirements.

No. Storage location is one element; you also need lawful basis for processing (Article 6), appropriate technical and organisational measures (Article 32), a Data Protection Impact Assessment for high-risk processing (Article 35), and a processor agreement (Article 28). EU-based storage simplifies Chapter V transfer obligations but does not replace the broader compliance framework.

Read the Data Processing Addendum and the vendor's privacy policy. GDPR Article 28(3)(a) prohibits processors from using personal data for purposes beyond those instructed by the controller unless required by law. If the vendor reserves the right to use transcripts for model improvement, it must obtain explicit consent or rely on legitimate interest, and you should evaluate whether that practice aligns with your patients' expectations. MedicMic does not use customer transcripts for model training.